AZN - AstraZeneca PLC

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5103.9B
Enterprise Value 3123.69B
Trailing P/E 42.34
Forward P/E 119.81
PEG Ratio (5 yr expected) 11.38
Price/Sales (ttm)4.64
Price/Book (mrq)10.07
Enterprise Value/Revenue 35.52
Enterprise Value/EBITDA 625.47

Trading Information

Stock Price History

Beta (3Y Monthly) 0.53
52-Week Change 38.18%
S&P500 52-Week Change 37.27%
52 Week High 343.30
52 Week Low 335.30
50-Day Moving Average 340.08
200-Day Moving Average 339.41

Share Statistics

Avg Vol (3 month) 33.51M
Avg Vol (10 day) 32.16M
Shares Outstanding 52.62B
Float 2.62B
% Held by Insiders 10.01%
% Held by Institutions 119.37%
Shares Short (Jun 28, 2019) 411.86M
Short Ratio (Jun 28, 2019) 44.78
Short % of Float (Jun 28, 2019) 4N/A
Short % of Shares Outstanding (Jun 28, 2019) 40.45%
Shares Short (prior month May 31, 2019) 412.62M

Dividends & Splits

Forward Annual Dividend Rate 41.4
Forward Annual Dividend Yield 43.48%
Trailing Annual Dividend Rate 32.80
Trailing Annual Dividend Yield 36.96%
5 Year Average Dividend Yield 44.17
Payout Ratio 4147.37%
Dividend Date 3Mar 27, 2019
Ex-Dividend Date 4Feb 28, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Jul 27, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 10.75%
Operating Margin (ttm)9.64%

Management Effectiveness

Return on Assets (ttm)2.17%
Return on Equity (ttm)17.27%

Income Statement

Revenue (ttm)22.4B
Revenue Per Share (ttm)8.84
Quarterly Revenue Growth (yoy)6.00%
Gross Profit (ttm)17.59B
EBITDA 4.86B
Net Income Avi to Common (ttm)2.41B
Diluted EPS (ttm)0.95
Quarterly Earnings Growth (yoy)74.40%

Balance Sheet

Total Cash (mrq)4.96B
Total Cash Per Share (mrq)1.89
Total Debt (mrq)21.61B
Total Debt/Equity (mrq)179.66
Current Ratio (mrq)0.75
Book Value Per Share (mrq)4.00

Cash Flow Statement

Operating Cash Flow (ttm)2.37B
Levered Free Cash Flow (ttm)6.29B